# New Designed ePTFE Valved Conduits for Surgical Reconstruction of Right-ventricular Outflow Tract

Study · id `cardio:ct-nct04152967` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04152967](<https://clinicaltrials.gov/study/NCT04152967>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04152967

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT04152967. Randomized; no masking; primary purpose treatment. Start 2020-04-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT04152967, source copy `cardio:ctgov-nct04152967-2021-10-22`, retrieved 2026-10-26)
- Started: 2020-04-01 (actual) (ClinicalTrials.gov record NCT04152967, source copy `cardio:ctgov-nct04152967-2021-10-22`, retrieved 2026-10-26)
- Primary completion: 2021-12-31 (anticipated) (ClinicalTrials.gov record NCT04152967, source copy `cardio:ctgov-nct04152967-2021-10-22`, retrieved 2026-10-26)
- Completion: 2022-11-30 (anticipated) (ClinicalTrials.gov record NCT04152967, source copy `cardio:ctgov-nct04152967-2021-10-22`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04152967, source copy `cardio:ctgov-nct04152967-2021-10-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04152967-2021-10-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: New Designed ePTFE Valved Conduits for Surgical Reconstruction of Right-ventricular Outflow Tract
- Condition: Right Ventricular Outflow Tract Absent
- Condition: Congenital Heart Disease
- Condition: Pulmonary Valve Disorders
- Intervention (Device): new-designed PTFE valved conduits
- Intervention (Device): Bovine jugular vein valved conduits
- Lead sponsor: Children's Hospital of Fudan University
- Lead sponsor class: OTHER
- Collaborator: Shanghai Zhongshan Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai Children's Medical Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as a collaborator: Shanghai Zhongshan Hospital (`cardio:org-shanghai-zhongshan-hospital`)

## Provenance

Content hash: 05f4a784047ef8239e044f48fced9ac1e5e7709c227dce5783d774632b3e1078
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
